Show simple item record

dc.contributor.authorTaheri, Y
dc.contributor.authorSuleria, HAR
dc.contributor.authorMartins, N
dc.contributor.authorSytar, O
dc.contributor.authorBeyatli, A
dc.contributor.authorYeskaliyeva, B
dc.contributor.authorSeitimova, G
dc.contributor.authorSalehi, B
dc.contributor.authorSemwal, P
dc.contributor.authorPainuli, S
dc.contributor.authorKumar, A
dc.contributor.authorAzzini, E
dc.contributor.authorMartorell, M
dc.contributor.authorSetzer, WN
dc.contributor.authorMaroyi, A
dc.contributor.authorSharifi-Rad, J
dc.date.accessioned2020-11-27T00:39:35Z
dc.date.available2020-11-27T00:39:35Z
dc.date.issued2020-08-01
dc.identifierpii: 10.1186/s12906-020-03033-z
dc.identifier.citationTaheri, Y., Suleria, H. A. R., Martins, N., Sytar, O., Beyatli, A., Yeskaliyeva, B., Seitimova, G., Salehi, B., Semwal, P., Painuli, S., Kumar, A., Azzini, E., Martorell, M., Setzer, W. N., Maroyi, A. & Sharifi-Rad, J. (2020). Myricetin bioactive effects: moving from preclinical evidence to potential clinical applications. BMC COMPLEMENTARY MEDICINE AND THERAPIES, 20 (1), https://doi.org/10.1186/s12906-020-03033-z.
dc.identifier.issn2662-7671
dc.identifier.urihttp://hdl.handle.net/11343/252542
dc.description.abstractSeveral flavonoids have been recognized as nutraceuticals, and myricetin is a good example. Myricetin is commonly found in plants and their antimicrobial and antioxidant activities is well demonstrated. One of its beneficial biological effects is the neuroprotective activity, showing preclinical activities on Alzheimer, Parkinson, and Huntington diseases, and even in amyotrophic lateral sclerosis. Also, myricetin has revealed other biological activities, among them as antidiabetic, anticancer, immunomodulatory, cardiovascular, analgesic and antihypertensive. However, few clinical trials have been performed using myricetin as nutraceutical. Thus, this review provides new insights on myricetin preclinical pharmacological activities, and role in selected clinical trials.
dc.languageEnglish
dc.publisherBMC
dc.rights.urihttps://creativecommons.org/licenses/by/4.0
dc.titleMyricetin bioactive effects: moving from preclinical evidence to potential clinical applications
dc.typeJournal Article
dc.identifier.doi10.1186/s12906-020-03033-z
melbourne.affiliation.departmentAgriculture and Food Systems
melbourne.source.titleBMC Complementary and Alternative Medicine
melbourne.source.volume20
melbourne.source.issue1
dc.rights.licenseCC BY
melbourne.elementsid1463344
melbourne.contributor.authorSuleria, Hafiz Ansar Rasul
dc.identifier.eissn2662-7671
melbourne.accessrightsOpen Access


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record